Heron Therapeutics Announces Rescheduled Earnings Call for Q2 2025
Heron Therapeutics, Inc. (NASDAQ: HRTX), a leading biotechnology company dedicated to enhancing patient care through innovative medical solutions, has decided to change the date of its second quarter 2025 earnings release. The Company will now hold its live conference call and webcast on Friday, August 8, 2025, at 8:30 a.m. ET, allowing stakeholders to engage in discussions about the latest financial results and significant updates in the business.
Details of the Upcoming Conference Call
Participants can join the conference call by using a registration link that will provide them with dial-in information. For an optimal experience, attendees are encouraged to connect fifteen minutes prior to the start time. Additionally, this important call will be accessible via webcast under the Investor Relations section of Heron Therapeutics' website. An archive of the call will be available for 60 days, ensuring everyone has the opportunity to catch up on the insights shared.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is committed to revolutionizing the treatment landscape for patients in acute and oncology care through the development and commercialization of groundbreaking therapeutic products. With a focus on advanced science and proprietary technologies, Heron is dedicated to improving the quality of life for patients by providing innovative treatment options. To explore further about their ongoing initiatives and products, visit www.herontx.com.
Investor Relations Team
If you would like to reach out for more information or inquiries, please contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
Phone: 858-251-4400
Frequently Asked Questions
What is the new date for Heron Therapeutics' Q2 2025 earnings release?
The new date for the earnings release is Friday, August 8, 2025.
How can I participate in the conference call?
Participants can access the conference call through a registration link that provides dial-in details.
Where can I find the webcast of the conference call?
The webcast will be available under the Investor Relations section of Heron Therapeutics' website.
Who should I contact for more information regarding Heron Therapeutics?
You can contact Ira Duarte, Executive Vice President, Chief Financial Officer, at iduarte@herontx.com.
What is the mission of Heron Therapeutics?
Heron Therapeutics aims to enhance patient care by developing and commercializing therapeutic innovations that address significant medical needs.